Bausch Health Companies (BHC) Asset Writedowns and Impairment (2009 - 2026)
Bausch Health Companies (BHC) posted Asset Writedowns and Impairment of $9.0 million for Q2 2026, up 28.57% sequentially from $7.0 million in Q4 2025.
Bausch Health Companies (BHC) Asset Writedowns and Impairment (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Asset Writedowns and Impairment for 13 years, with the latest figure at $9.0 million in Q2 2026.
- Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $9.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $17.0 million (down 26.09% YoY) and the FY2025 annual result came in at $8.0 million, down 72.41% from the prior year.
- Asset Writedowns and Impairment grew to $9.0 million in Q2 2026 per BHC's latest filing, from $7.0 million in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $37.0 million in Q2 2023 and troughed at $1.0 million in Q3 2022.
- A 5-year average of $9.6 million and a median of $6.5 million in 2022 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2022 and 2023: Asset Writedowns and Impairment sank 94.59% in 2022, then jumped 516.67% in 2023.
- Over 5 years, Asset Writedowns and Impairment stood at $1.0 million in 2022, then jumped by 300.0% to $4.0 million in 2023, then soared by 475.0% to $23.0 million in 2024, then tumbled by 69.57% to $7.0 million in 2025, then gained by 28.57% to $9.0 million in 2026.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $9.0 million, $7.0 million, and $1.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Bausch Health Companies | 2.56 Bn | 725.13 Mn | 2.10 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.00 Mn |
| Jun 30, 2026 | 9.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Dec 31, 2024 | 23.00 Mn |
| Dec 31, 2024 | 23.00 Mn |
| Jun 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 5.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 37.00 Mn |
| Jun 30, 2023 | 37.00 Mn |
| Mar 31, 2023 | 13.00 Mn |
| Mar 31, 2023 | 13.00 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Sep 30, 2022 | 1.00 Mn |